Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-Q Pro-Longevity Serum + IPL for Photodamage and Crepiness
NCT07686198Phase 3Not yet recruiting
- Sponsor
- Cosmetic Laser Dermatology
- Start
- Jul 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in photoaging (2 arms), sponsored by Cosmetic Laser Dermatology. Primary endpoint: Physician Global Aesthetic Improvement Scale at Day 84. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
photoaging
Beyond the preview
Go deeper on NCT07686198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686198.